Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
CALL
HealthEquity
HQY
$8.81B
| $1.11M | ﹤0.01% |
15,000
+10,000
| +200% | +$703K |
|
2777
Roper Technologies
ROP
$40.9B
| $1.11M | ﹤0.01% |
3,237
-23,921
| -88% | -$7.26M |
|
|
PRAH
2778
PUT
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.1M | ﹤0.01% |
+10,000
| New | +$1.05M |
|
|
TARO
2779
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.1M | ﹤0.01% |
10,154
-6,708
| -40% | -$668K |
|
2780
Savara
SVRA
$1.15B
| $1.09M | ﹤0.01% |
148,517
+54,152
| +57% | +$408K |
|
2781
Markel Group
MKL
$22.4B
| $1.09M | ﹤0.01% |
1,097
-14,844
| -93% | -$15.1M |
|
2782
Penske Automotive Group
PAG
$14.4B
| $1.09M | ﹤0.01% |
24,489
-140,828
| -85% | -$6.24M |
|
2783
Black Hills Corp
BKH
$5.57B
| $1.09M | ﹤0.01% |
+14,724
| New | +$1.01M |
|
|
TTCF
2784
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $1.09M | ﹤0.01% |
+110,005
| New | +$1.08M |
|
2785
Westwood Holdings Group
WHG
$188M
| $1.09M | ﹤0.01% |
30,900
+6,383
| +26% | +$239K |
|
2786
Schwab US Broad Market ETF
SCHB
$44.6B
| $1.09M | ﹤0.01% |
95,976
-16,050
| -14% | -$175K |
|
2787
PUT
Biogen
BIIB
$32.6B
| $1.09M | ﹤0.01% |
4,600
| – | – |
|
|
VNET
2788
VNET Group
VNET
$1.96B
| $1.09M | ﹤0.01% |
136,863
-600,189
| -81% | -$5.37M |
|
|
STND
2789
DELISTED
Standard AVB Financial Corp. Common Stock
STND
| $1.08M | ﹤0.01% |
40,176
+4,911
| +14% | +$147K |
|
|
JT
2790
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $1.08M | ﹤0.01% |
+26,997
| New | +$1.26M |
|
2791
Fossil Group
FOSL
$323M
| $1.08M | ﹤0.01% |
78,775
-375,995
| -83% | -$5.99M |
|
2792
Costamare
CMRE
$1.91B
| $1.08M | ﹤0.01% |
207,139
+123,817
| +149% | +$623K |
|
|
AVID
2793
DELISTED
Avid Technology Inc
AVID
| $1.08M | ﹤0.01% |
144,540
+122,877
| +567% | +$638K |
|
|
KDNY
2794
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.08M | ﹤0.01% |
54,096
+30,821
| +132% | +$537K |
|
|
HR
2795
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.07M | ﹤0.01% |
33,485
+24,892
| +290% | +$781K |
|
2796
Mueller Industries
MLI
$13.6B
| $1.07M | ﹤0.01% |
136,764
-120,460
| -47% | -$886K |
|
2797
Commercial Vehicle Group
CVGI
$126M
| $1.07M | ﹤0.01% |
139,404
+14,586
| +12% | +$109K |
|
2798
SoundThinking
SSTI
$81M
| $1.07M | ﹤0.01% |
27,689
-31,911
| -54% | -$1.37M |
|
2799
GrafTech
EAF
$175M
| $1.07M | ﹤0.01% |
8,339
+4,116
| +97% | +$547K |
|
2800
Harrow
HROW
$1.55B
| $1.07M | ﹤0.01% |
+214,342
| New | +$1.3M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.